The largest mechanical thrombectomy study in the field of DVT evaluating real world patient outcomes after treatment with the ClotTriever® system.
A lytic-free approach enabling decreased hospital resource utilization
Significant thrombus removal to provide patients with sustained benefits at 30 days
n= 486
Complete or near-complete thrombus removal
n= 393
Free of moderate or severe PTS symptoms at 30 days
Restoring flow with an unmatched safety profile
Device-related SAEs
n= 499
Vessel damage
Valve damage
Acute kidney injury (AKI)
n= 424
Request more information. Request more information. Request more information. Request more information. Request more information. Request more information.
Request
